Joanna Horobin - Net Worth and Insider Trading

Joanna Horobin Net Worth

The estimated net worth of Joanna Horobin is at least $777 dollars as of 2024-05-17. Joanna Horobin is the Chief Medical Officer of Aceragen Inc and owns about 2,044 shares of Aceragen Inc (ACGN) stock worth over $777. Details can be seen in Joanna Horobin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joanna Horobin has not made any transactions after 2018-12-20 and currently still holds the listed stock(s).

Transaction Summary of Joanna Horobin

To

Joanna Horobin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joanna Horobin owns 5 companies in total, including Kymera Therapeutics Inc (KYMR) , Liquidia Corp (LQDA) , and Aceragen Inc (ACGN) among others .

Click here to see the complete history of Joanna Horobin’s form 4 insider trades.

Insider Ownership Summary of Joanna Horobin

Ticker Comapny Transaction Date Type of Owner
KYMR Kymera Therapeutics Inc 2020-08-20 director
LQDA Liquidia Corp 2021-03-24 director
ACGN Aceragen Inc 2018-12-20 Chief Medical Officer
2012-10-23 Chief Medical Officer
2021-03-30 director

Joanna Horobin Latest Holdings Summary

Joanna Horobin currently owns a total of 1 stock. Joanna Horobin owns 2,044 shares of Aceragen Inc (ACGN) as of December 20, 2018, with a value of $777.

Latest Holdings of Joanna Horobin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACGN Aceragen Inc 2018-12-20 2,044 0.38 777

Holding Weightings of Joanna Horobin


Joanna Horobin Form 4 Trading Tracker

According to the SEC Form 4 filings, Joanna Horobin has made a total of 0 transactions in Aceragen Inc (ACGN) over the past 5 years. The most-recent trade in Aceragen Inc is the acquisition of 300 shares on December 20, 2018, which cost Joanna Horobin around $1,035.

Insider Trading History of Joanna Horobin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joanna Horobin Trading Performance

GuruFocus tracks the stock performance after each of Joanna Horobin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joanna Horobin is -3.37%. GuruFocus also compares Joanna Horobin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joanna Horobin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joanna Horobin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joanna Horobin

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.12
Relative Return to S&P 500(%) -18.36

Joanna Horobin Ownership Network

Ownership Network List of Joanna Horobin

No Data

Ownership Network Relation of Joanna Horobin


Joanna Horobin Owned Company Details

What does Kymera Therapeutics Inc do?

Who are the key executives at Kymera Therapeutics Inc?

Joanna Horobin is the director of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include 10 percent owner Atlas Venture Fund X, L.p. , Chief Medical Officer Jared Gollob , and Chief Financial Officer Bruce N. Jacobs .

Kymera Therapeutics Inc (KYMR) Insider Trades Summary

Over the past 18 months, Joanna Horobin made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 989,618 shares made by Bruce Booth , a net sale of 862,075 shares made by Atlas Venture Fund X, L.p. , and a net sale of 49,881 shares made by Jared Gollob .

In summary, during the past 3 months, insiders sold 846,935 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 846,935 shares. During the past 18 months, 1,925,173 shares of Kymera Therapeutics Inc (KYMR) were sold and 455,112 shares were bought by its insiders, resulting in a net sale of 1,470,061 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kymera Therapeutics Inc Insider Transactions

No Available Data

Joanna Horobin Mailing Address

Above is the net worth, insider trading, and ownership report for Joanna Horobin. You might contact Joanna Horobin via mailing address: 215 First Street, Suite 440, Cambridge Ma 02142.

Discussions on Joanna Horobin

No discussions yet.